Publications by authors named "Xintao Qiu"

16Publications

Integrative analyses of single-cell transcriptome and regulome using MAESTRO.

Genome Biol 2020 08 7;21(1):198. Epub 2020 Aug 7.

Department of Data Science, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13059-020-02116-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412809PMC
August 2020

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

Mol Cell 2020 06 15;78(6):1096-1113.e8. Epub 2020 May 15.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2020.04.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306005PMC
June 2020

Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer.

Int J Oncol 2018 Nov 9;53(5):1857-1868. Epub 2018 Aug 9.

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2018.4519DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192729PMC
November 2018

A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer.

Cell 2018 07 14;174(2):422-432.e13. Epub 2018 Jun 14.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00928674183064
Publisher Site
http://dx.doi.org/10.1016/j.cell.2018.05.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046260PMC
July 2018

Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations.

Cancer Cell 2018 02;33(2):173-186.e5

Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Boston, MA 02210, USA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02210, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02210, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.01.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813700PMC
February 2018

Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes.

Transl Oncol 2017 Feb 22;10(1):99-107. Epub 2016 Dec 22.

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing, 100050, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2016.11.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198736PMC
February 2017